Events & presentations

Internal link Webcast of Presentation of QR-421a Phase 1/2 Stellar Trial Results

Company management will present and discuss results from its Phase 1/2 Stellar trial of QR-421a in adults with Usher syndrome and non-syndromic retinitis pigmentosa (nsRP).

• Add Webcast of Presentation of QR-421a Phase 1/2 Stellar Trial Results to calender

Internal link JMP Securities Grand Rounds KOL Call | PRQR Phase 1/2 Stellar Data in Usher Syndrome

Featuring Dr. David Birch, Ph.D.
Hosted by JMP Securities Biotech Analyst Jonathan Wolleben

• Add JMP Securities Grand Rounds KOL Call | PRQR Phase 1/2 Stellar Data in Usher Syndrome to calender

Internal link Expert Perspectives Series - Disease Education and Endpoints in Usher Syndrome

Aniz Girach, MD, Chief Medical Officer, and Paul Yang, MD, PhD, Casey Eye Institute will discuss which vision measures are most informative in Usher syndrome, the role of baseline and disease progression, and objectives of the Stellar trial.

• Add Expert Perspectives Series - Disease Education and Endpoints in Usher Syndrome to calender

Internal link Evercore ISI Measuring Vision Webinar - Part 2

Hosted by Josh Schimmer at Evercore ISI, this webinar featuring Aniz Girach, MD, Chief Medical Officer takes a deep dive into vision endpoints for IRDs.

• Add Evercore ISI Measuring Vision Webinar - Part 2 to calender

Internal link Evercore ISI Measuring Vision Webinar - Part 1

Hosted by Josh Schimmer at Evercore ISI, this webinar featuring Aniz Girach, MD, Chief Medical Officer takes a deep dive into vision endpoints for IRDs.

• Add Evercore ISI Measuring Vision Webinar - Part 1 to calender